It has been discovered that the abnormal accumulation of Aβ induces ERS and activates the UPR and its downstream signaling pathways, upregulating NF-κB to activate glial cells, induce neuroinflammation, and exacerbate the progression of AD (Salminen et al., 2020). Here, NFKB1 is linked to Alzheimer disease.